Ozgur Sahin was recognized for his work and article, “Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer,” published by Nature Communications Nov. 2, 2023.
We participated in the AACR conference with three distinct poster presentations.
https://hollingscancercenter.musc.edu/news/archive/2024/02/06/hollings-researchers-demonstrate-restoring-effectiveness-of-breast-cancer-drug-after-resistance
We are thrilled to share the news that Ozge, our PhD candidate, has successfully defended her thesis entitled “Targeted Multimodal Approaches to Treat Aggressive Breast Cancers via Therapeutic Inhibition of Key Vulnerabilities.” Her completion of Read more…
0 Comments